Biovalence Technologies is a recombinant proteomics biotech that wants to make a positive impact on human and animal lives. RetroMAD1 is one of two novel, well-defined chimeric proteins with anti-viral properties that can be given orally. Proof of concept, animal studies and clinical trials in pets have shown RetroMAD1 to be effective in reducing clinical signs and/or death resulting from viral infections due to CDV, CPV2, FeLV, FIV and FIPV.
The company is now generating revenue in the pet healthcare market while saving lives of cats suffering from feline leukemia, feline infectious peritonitis, and puppies from canine parvovirosis. We are touched to continue receiving many cat owners’ and cat shelters’ emails on the positive effect that RetroMAD1 has on their feline family members, thriving with a good quality of life.
In humans, the company has generated data against Herpes, Dengue, AIDS and Ebola. It’s now moving rapidly to work on Covid-19 with partners. Scientists have recently discovered that Sars-CoV2 has a mutation close to that of DENV, HIV, EBOV and FIPV that activates the host cell’s furin protease, allowing rapid invasion.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 7500a Beach Road, Unit 06-307,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- biovalence.com
- Keywords
- Biopharmaceuticals, Antiviral therapeutic, Recombinant proteomics, Bioprocessing, Healthcare, Animal health, Viral diseases.
- HQ
- Singapore
Biovalence Technologies Pte Ltd Questions
Biovalence Technologies Pte Ltd's website is biovalence.com
Biovalence Technologies Pte Ltd's LinkedIn profile is https://sg.linkedin.com/company/biovalence-technologies-pte-ltd
Biovalence Technologies Pte Ltd has
6 employees.
View email and phone details for 6
employees at Biovalence Technologies Pte Ltd.
Biovalence Technologies Pte Ltd's industry is
Biotechnology Research
Biovalence Technologies Pte Ltd's top competitors are
Lunoji,
Genome Solutions,
Novogeneait Genomics,
Chesc-Sc Icheme,
Omicshealthtech Llc,
Toby Supplies Pte Ltd,
Panomix (Singapore) Pte. Ltd.,
Waterskiworks,
T-Cyte Therapeutics,
Sharif Omics Services.
Biovalence Technologies Pte Ltd's categories are Biotechnology Research
Biovalence Technologies Pte Ltd's founding year is 2011
